Evan Anderson, CEO & Board Member, Luma Therapeutics
Evan Anderson, CEO and Board Member of Luma Therapeutics, has 17 years of experience in early stage product and market development. He completed the Stanford Biodesign Fellowship in 2004 and was first manager of R&D and then distribution sales at Spiracur (acquired by Acelity).
From the Luma Therapeutics website:
We are a medical device company developing light therapies for the 40 million people in the US with inflammatory skin disorders. Luma Therapeutics was born when our CEO Evan Anderson found that he had psoriasis and discovered a way to treat himself effectively. He knew then that he wanted to develop similar treatments for the millions of other people suffering from skin disorders.
We work hard every day to help people get clear skin with easy to use, affordable therapies.
Our goal is to develop an at home treatment that will put psoriasis in remission for an extended period of time after only a few weeks of therapy.
Liz Kislik: Conflict Managed
Jay Johnson: Behavioral Intelligence
Lindy Fishburne: “Break Out” Into a New Space
Arvind Rajan: Transformative Care
Frank Dobbin: Commitment to Change
Guy Friedman: Building Trust
Lorin Gu: Problem Solvers With Capital
Nada Hanafi: See It, Believe It
Maureen Shaffer: How to Tell Your Story
Manav Sevak: The Care in Care Delivery
Kyle Kiser: A Tough Pill to Swallow
Julie Wroblewski: Investing in the Future
Rajit Kamal: Leading with Vulnerability
Prentice Tom: Sounds of Mental Illness
Anne Tumlinson: Step Off the Cliff
Marcus Whitney: Orchestrating Change
John Kao: The Servant Leader
Nagraj Kashyap: Art, Not Science
Vivian Lee: We Are All Unique
Mike Snyder: The System is Broken
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money